DSP 8658
Alternative Names: DSP-8658Latest Information Update: 05 Nov 2023
At a glance
- Originator Dainippon Sumitomo Pharma
- Class Antihyperglycaemics
- Mechanism of Action Peroxisome proliferator-activated receptor alpha agonists; Peroxisome proliferator-activated receptor gamma agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Alzheimer's disease; Type 2 diabetes mellitus
Most Recent Events
- 30 Sep 2013 Discontinued - Phase-I for Alzheimer's disease & Type-2 diabetes mellitus in USA (PO)
- 16 Sep 2011 Sunovion completes a phase I trial in Type-2 diabetes mellitus in USA (NCT01042106)
- 03 Feb 2011 Phase-I clinical trials in Alzheimer's disease in USA (PO)